Drugs to stop alcohol cravings
Pro Research Analysisby 
Searched over 200M research papers
Effective Drugs to Stop Alcohol Cravings
Gabapentin for Reducing Alcohol Consumption and Cravings
Gabapentin, an anticonvulsant, has shown promising results in reducing alcohol consumption and cravings. A randomized, double-blind, placebo-controlled trial demonstrated that a 28-day treatment with gabapentin significantly reduced the number of drinks per day and the percentage of heavy drinking days. Additionally, it increased the percentage of days of abstinence compared to a placebo group. The study also noted improvements in obsessive-compulsive symptoms related to drinking, suggesting gabapentin's potential in maintaining abstinence with minimal side effects .
Naltrexone: An Opioid Antagonist for Alcohol Dependence
Naltrexone, an opioid receptor antagonist, is widely recognized for its efficacy in reducing alcohol cravings and consumption. Clinical studies have shown that naltrexone decreases the desire to drink and the amount of alcohol consumed. It works by activating the hypothalamo-pituitary-adrenocortical axis, which is associated with reduced alcohol craving. Naltrexone-treated subjects reported lower levels of craving and consumed fewer drinks compared to those on a placebo . This medication is considered a gold standard for promoting abstinence and relieving cravings in alcohol-dependent individuals .
Baclofen: A GABA(B) Receptor Agonist
Baclofen, a GABA(B) receptor agonist, has been effective in reducing alcohol intake and cravings. Preliminary studies indicate that baclofen can induce and maintain abstinence, reduce obsessive and compulsive components of craving, and decrease alcohol consumption. Patients treated with baclofen showed a higher percentage of abstinence and a significant reduction in craving levels compared to those on a placebo. Baclofen was well-tolerated, with no significant side effects leading to discontinuation .
Acamprosate: Modulating Glutamatergic Neurotransmission
Acamprosate, another medication approved for treating alcohol dependence, interacts with NMDA receptor-mediated glutamatergic neurotransmission. It has been effective in reducing cravings and preventing relapse in alcohol-dependent individuals. Acamprosate's mechanism involves reducing calcium fluxes through voltage-operated channels, which helps in stabilizing the chemical balance in the brain disrupted by chronic alcohol use .
Combination Therapies: Oxytocin and Naltrexone
Recent studies have explored the combined effects of oxytocin and naltrexone on alcohol cravings. Oxytocin, administered intranasally, has shown beneficial effects on alcohol craving and stress reactivity. When combined with naltrexone, it may enhance the reduction of alcohol cravings and improve treatment outcomes. This combination therapy is currently being investigated in clinical trials to assess its efficacy in reducing stress-induced and alcohol cue-induced cravings.
Conclusion
Several medications have shown efficacy in reducing alcohol cravings and consumption, including gabapentin, naltrexone, baclofen, and acamprosate. These drugs work through different neurobiological pathways, offering various options for treating alcohol dependence. Combination therapies, such as oxytocin with naltrexone, are also being explored to enhance treatment outcomes. These pharmacological approaches provide valuable tools for managing alcohol cravings and supporting long-term abstinence in individuals with alcohol use disorders.
Sources and full results
Most relevant research papers on this topic